Oncologists Accepting CurativePage 11

Henry Pitot, M.D.

Associate Professor, Oncology

Oncology

Efrat Dotan, MD

Executive Medical Director

Oncology

Jennifer Yu, MD, PHD

Founding Director, Center for Hyperthermia

Oncology

Catherine Park, M.D.

Professor and Chair, Department of Radiation Oncology, UCSF

Oncology

Bonnie Joe, M.D.

Professor, Radiology

Oncology

Spiros Hiotis, M.D.

Associate Professor, Surgery

Oncology

Russell Pachynski, MD

Associate Professor of Medicine, Division of Oncology, Washington University School of Medicine

Oncology

Henry Kuerer, M.D.

Director, Breast Surgical Oncology Training Program

Oncology

John Donahue, MD

Clinician in Radiology and Biomedical Imaging, Yale School of Medicine

Oncology

Julie Margenthaler, MD

Professor of Surgery and Director of the Breast Fellowship Program, Washington University School of Medicine; Director of Breast Surgical Services, Joanne Knight Breast Center at Siteman Cancer Center

Oncology

Andrew Ashikari, MD FACS

Associate Professor of Surgery

Oncology

John Levine, MD

Professor | Medicine, Hematology and Medical Oncology; Professor | Pediatrics; Co-Director, Mount Sinai Acute GVHD International Consortium (MAGIC); Director of BMT Clinical Research, Tisch Cancer Institute

Oncology

Eric Small, MD

Genitourinary Medical Oncology

Oncology

Scott Karlan, M.D.

Clinical Professor of Surgery, UCLA

Oncology

Elad Sharon, M.D.

Director of the Immunotherapy Toxicity Program and a Member of the Faculty of Medicine at Harvard Medical School. From 2011 through August 2023, Dr. Sha

Oncology

Stefan Zimmerman, MD

Oncology

Mark Sugi, M.D.

Senior Associate Consultant, Department of Radiology

Oncology

Steven Clinton, MD, PHD

Director, Genitourinary Oncology

Oncology

William Chapman, MD

Assistant Professor of Surgery, Colon and Rectal Surgery

Oncology

William Hahn, MD PHD

Professor of Medicine in the Department of Medical Oncology at Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Ins; Chief Operating and Transformation Officer at the Dana-Farber Cancer Institute.

Oncology